Best GLP-1 Providers That Take Insurance in 2026: Ranked and Reviewed
Insurance can pay for an FDA-approved GLP-1 such as Wegovy, Zepbound, Ozempic or Mounjaro. It does not pay for compounded semaglutide or tirzepatide, which is sold for cash. Whether your plan covers weight management at all is decided by the plan, often by the employer that funds it. The sellers below are the ones whose own descriptions say they accept insurance or coordinate it for you. That is a statement about how the seller bills, not a promise about your coverage, so ask whether it is in network with your plan and whether it handles prior authorization before you book.
Lowest verified price: $140/mo23 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
23 GLP-1 providers that take insurance compared · independently scored against our six-factor methodology.
Quick Picks
How coverage gets decided
$50
Medicare GLP-1 Bridge copay a month
Since July 1, 2026, Medicare's temporary GLP-1 Bridge covers Foundayo, Wegovy (injection or tablet) and the Zepbound KwikPen for eligible people with Part D drug coverage, at a $50 copay for a month's supply. Approvals hold through December 31, 2027.[12]
Who qualifies for the Bridge →3 exclusions
diagnoses that route you to Part D
Medicare.gov turns away anyone with type 2 diabetes, moderate or severe sleep apnea, or fatty liver disease, and points them back to their Part D plan, which might pay for a GLP-1 on those grounds.[12]
The Bridge in full →Beyond weight
approved uses some plans treat differently
Zepbound carries a sleep apnea indication for adults with obesity, and Wegovy injection carries two more: heart risk in people with heart disease, and one kind of fatty liver disease. A plan that excludes weight-loss drugs may review those uses under other rules.[13]
How to get a GLP-1 covered →Appeal
internal appeal, then external review
When a plan denies a covered drug, you can ask the plan to reconsider and, if it refuses, ask for an independent external review. An exclusion written into the plan is harder to overturn than a denial of a covered benefit.[14]
Denials versus exclusions →
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
an oral route if you will not self-inject
From /mo$149Scales with doseCoverage50 statesMedicationsSemaglutide - Best Budget
coaching and unlimited provider visits bundled into a 12-month compounded program
From /mo$140CoverageCheck intakeMedicationsSemaglutideTirzepatide - Best Care Team
people who want semaglutide alongside hormone care, with insurance-billed visits and nutrition coaching
From /mo$175Scales with doseCoverage47 states + DCMedicationsSemaglutide
Show 5 moreShow fewer
seeing what it charges before you answer any medical questions
From /mo$199Coverage31 statesMedicationsSemaglutideTirzepatide- Nationwide Coverage
coaching bundled into the price rather than sold separately
From /moCheck pricingCoverage50 statesMedicationsSemaglutide insured patients who want help getting a brand-name GLP-1 covered, with a cash plan as backup
From /mo$151+ membershipCoverage50 states + DCMedicationsSemaglutideTirzepatideseeing what it charges before you answer any medical questions
From /mo$299CoverageCheck intakeMedicationsSemaglutideTirzepatidean oral route if you will not self-inject
From /mo$149prepaidFlat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick an oral route if you will not self-inject | $149 Scales by dose | Semaglutide | 50 states | Visit → | |
Best Budget coaching and unlimited provider visits bundled into a 12-month compounded program | $140 | SemaglutideTirzepatide | Check intake | Visit → | |
Best Care Team people who want semaglutide alongside hormone care, with insurance-billed visits and nutrition coaching | $175 Scales by dose | Semaglutide | 47 states + DC | Visit → | |
 seeing what it charges before you answer any medical questions | $199 | SemaglutideTirzepatide | 31 states | Visit → | |
Nationwide Coverage coaching bundled into the price rather than sold separately | Check pricing | Semaglutide | 50 states | Visit → | |
 insured patients who want help getting a brand-name GLP-1 covered, with a cash plan as backup | $151+ membership | SemaglutideTirzepatide | 50 states + DC | Visit → | |
 seeing what it charges before you answer any medical questions | $299 | SemaglutideTirzepatide | Check intake | Visit → | |
 an oral route if you will not self-inject | $149prepaid Flat pricing | SemaglutideTirzepatide | Check intake | Visit → |
All 23 providers on this board, in the order this board shows them
The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
NovoCare Pharmacy
Best for: an oral route if you will not self-inject
NovoCare Pharmacy is Novo Nordisk's own direct-to-patient pharmacy for Wegovy and, now, Ozempic. Self-pay Wegovy pills run $149 to $299 a month by dose, and new patients pay $199 for the first two months of a Wegovy or Ozempic pen before the $349 standard price; Wegovy HD is $399 and Ozempic 2 mg $499. It fills prescriptions but does not write them; it links to telehealth prescribers.
Score Breakdown
Pros
- ✓Semaglutide costs $349 a month, 73% below the $1,299 median for brand-name semaglutide across the sellers we compare
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to NovoCare Pharmacy
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
Ivim Health
Verified partnerBest for: coaching and unlimited provider visits bundled into a 12-month compounded program
Ivím Health sells compounded semaglutide from $65 a month and tirzepatide from $117 on a 12-month program, plus a $75 monthly program fee for membership care, so the floor is $140 or $192 a month. Membership covers unlimited provider visits and functional health coaches, and the first month of it is free. Zepbound and Wegovy are offered through a separate program with insurance checks. Canceling does not end the program early or refund fees. FDA sent Ivim Services LLC a warning letter in February 2026 over compounded GLP-1 claims.
Score Breakdown
Pros
- ✓Semaglutide costs $140 a month, 30% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $192 a month, 29% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and coaching
Cons
- ✗Confirm it serves your state before you start the intake
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗The FDA has issued Ivim Health a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Thrivelab
Best for: people who want semaglutide alongside hormone care, with insurance-billed visits and nutrition coaching
Score breakdown, pros and cons
Thrivelab is an online hormone clinic, best known for bioidentical hormone therapy and TRT, that also prescribes compounded semaglutide as a weekly injection or a daily dose taken under the tongue, with nutrition coaching on offer. Care starts with a 40-minute telehealth appointment, which it bills to insurance or charges cash. Semaglutide injections are $175 for the first month, then $175 to $250 a month by dose; oral semaglutide is $225 for the first month, then from $300. FDA sent it a warning letter in June 2026.
Score Breakdown
Pros
- ✓Semaglutide costs $175 a month, 12% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓Serves 47 states and DC
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗The FDA has issued Thrivelab a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- ✗Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Spry
Best for: seeing what it charges before you answer any medical questions
Score breakdown, pros and cons
Spry sells compounded semaglutide from $199 and compounded tirzepatide from $299, re-billed every four weeks with each new vial and no contract. A nurse practitioner reviews intake within 24 hours. The site names three co-founders and shows a LegitScript seal. It also shows an "FDA Approved" badge, which no compounded GLP-1 can claim.
Score Breakdown
Pros
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓We found no FDA warning letters issued to Spry
Cons
- ✗Serves only 31 states, so check that yours is one of them
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Calibrate Health
Best for: coaching bundled into the price rather than sold separately
Score breakdown, pros and cons
The program fee is $199/month and it buys no medication; the drug is billed apart and, with commercial insurance, can fall to roughly $25/month after the deductible. Calibrate's Metabolic Reset pairs a branded GLP-1 drug, Wegovy, Ozempic, Mounjaro, Zepbound or Foundayo, with one-to-one video coaching and a behavior curriculum. The first three months are a required commitment, $597 in all. Only branded drugs are used, and a 10% weight-loss result carries a money-back guarantee.
Score Breakdown
Pros
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes clinician visits and coaching
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Calibrate Health
- ✓A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- ✓Baseline bloodwork is required before a prescription
Cons
- ✗Not included in the monthly price: medication, lab work
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Related research
A seller that takes insurance can only bill what your plan covers. These pages cover how plans decide, what Medicare and Medicaid pay, and the cash route if coverage fails.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 12.Medicare.gov: Weight loss drugs, Medicare GLP-1 Bridge coverage, eligibility and costs— Centers for Medicare & Medicaid Services.
- 13.Wegovy (semaglutide) prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).
- 14.HealthCare.gov: Appealing a health plan decision, internal appeals and external review— Centers for Medicare & Medicaid Services.